Vestibular Schwannoma
📧 Sign up to get email alerts when something new happens for Vestibular Schwannoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas [Phase 2]
Phase 2 clinical trial of crizotinib in children and adults with Neurofibromatosis type 2 and progressive vestibular schwannomas has complet…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Vestibular Schwannoma Organoids
The clinical trial investigating vestibular schwannoma organoids has completed, with Maastricht Radiation Oncology listed as the sponsor.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma [Phase 2]
This Phase 2 clinical trial update reports on hearing outcomes after fractionated proton radiation therapy for vestibular schwannoma.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas [NA]
Clinical trial evaluating diffusion tensor tractography to define facial nerve position in vestibular schwannomas has completed. The study i…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors [Phase 2]
Phase 2 trial of selumetinib in Neurofibromatosis type II–related tumors was terminated, with results posted in 2025; the study included ves…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma [Phase 1]
Phase 1 trial of super-selective intra-arterial bevacizumab (Avastin) for vestibular schwannoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy [NA]
The clinical trial update reports termination of a study evaluating longitudinal recovery of head and trunk control in people with acquired …
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Auditory Nerve Test System During Vestibular Schwannoma Resection [NA]
Clinical trial update indicating the Auditory Nerve Test System study during vestibular schwannoma resection has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Nimodipine in Vestibular Schwanommas [Phase 2]
Phase 2 clinical trial update for nimodipine in vestibular schwannoma is reported with unclear status.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 [Phase 2]
Phase 2 trial update for microscopic fluorescence-guided resection of vestibular schwannoma using fluorescein sodium and YELLOW 560 complete…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma [EARLY_Phase 1]
An exploratory Phase 1 study evaluated the histone deacetylase inhibitor AR-42 in vestibular schwannoma and meningioma; the trial was termin…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas [Phase 2]
Phase 2 trial of axitinib in Neurofibromatosis Type 2 with progressive vestibular schwannomas completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors [Phase 2]
A Phase 2 clinical trial evaluating icotinib in patients with Neurofibromatosis Type 2 and related vestibular schwannomas has been completed…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Concentration and Activity of Lapatinib in Vestibular Schwannomas [EARLY_Phase 1]
Early-phase trial updating concentration and activity of lapatinib in vestibular schwannomas, completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
This clinical trial compares whole-exome sequencing of NF2-associated vestibular schwannomas with sporadic cases and correlates findings wit…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: RGD PET/MRI in Sporadic Vestibular Schwannoma [Phase 2]
Phase 2 clinical trial update on RGD PET/MRI in sporadic vestibular schwannoma (acoustic neuroma).
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) [Phase 2]
Phase 2 clinical trial evaluating bevacizumab for symptomatic vestibular schwannoma in patients with neurofibromatosis type 2 has completed …
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors [Phase 2]
A Phase 2 clinical trial evaluating Endostatin for vestibular schwannoma in Neurofibromatosis Type 2–related tumors has completed enrollment…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: A Study of Nilotinib in Growing Vestibular Schwannomas [Phase 2]
The Phase 2 study of nilotinib in growing vestibular schwannomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma [NA]
This update reports on a completed clinical trial evaluating vertigo perception and quality of life in patients after surgical treatment of …
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors [Phase 2]
Phase 2 study of lapatinib in children and adults with Neurofibromatosis Type 2 and NF2-related tumors has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Recovery of Visual Acuity in People With Vestibular Deficits [NA]
This clinical trial update reports results from a completed study on recovery of visual acuity in people with vestibular deficits, with resu…